Oric Pharmaceuticals

ORIC

Capitalización de mercado USD 957 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Fidelity Investments Boston, Massachusetts	USD 23.7 M	-USD 1.12 M	-331,784	-8%
2	2 Column Group San Francisco, California	USD 21 M	–	–	–
3	3 EcoR1 Capital San Francisco, California	USD 20.1 M	–	–	–
4	4 Alkeon Capital Management New York	USD 14.1 M	+USD 987 k	+292,284	+14%
5	5 Suvretta Capital Management New York	USD 11.2 M	–	–	–
6	6 Millennium Management New York	USD 11.1 M	+USD 1.2 M	+355,370	+23%
7	7 OrbiMed New York	USD 9.47 M	-USD 1.62 M	-480,000	-23%
8	8 Vanguard Group Malvern, Pennsylvania	USD 9.11 M	+USD 673 k	+199,423	+15%
9	9 Boxer Capital San Diego, California	USD 7.36 M	–	–	–
10	10 Silverarc Capital Management Boston, Massachusetts	USD 7.28 M	+USD 92.2 k	+27,304	+2%
11	11 Prosight Management Dallas, Texas	USD 6.95 M	+USD 823 k	+243,666	+26%
12	12 Invus Financial Advisors New York	USD 5.93 M	–	–	–
13	13 BlackRock New York	USD 4.7 M	-USD 812 k	-240,554	-23%
14	EC 14 Euclidean Capital New York	USD 4.4 M	–	–	–
15	15 D.E. Shaw & Co New York	USD 3.55 M	+USD 233 k	+68,899	+13%
16	16 Memorial Sloan Kettering Cancer Center New York	USD 3.55 M	–	–	–
17	17 Monaco Asset Management Monaco	USD 3.28 M	+USD 730 k	+216,248	+63%
18	18 ArrowMark Colorado Holdings Denver, Colorado	USD 3.08 M	-USD 69.7 k	-20,654	-4%
19	AG 19 Artal Group Luxembourg	USD 2.36 M	–	–	–
20	20 UBS O'Connor Chicago, Illinois	USD 2.04 M	+USD 8.22 k	+2,433	+0.7%
21	21 Renaissance Technologies New York	USD 1.87 M	-USD 286 k	-84,600	-21%
22	22 Geode Capital Management Boston, Massachusetts	USD 1.67 M	-USD 2.02 k	-597	-0.2%
23	23 Oasis Management Company Grand Cayman, Cayman Islands	USD 1.6 M	–	–	–
24	24 DAFNA Capital Management Los Angeles, California	USD 1.56 M	-USD 504 k	-149,289	-36%
25	25 GSA Capital Partners London, United Kingdom	USD 1.4 M	+USD 43.1 k	+12,759	+6%

Oric Pharmaceuticals ORIC Capitalización de mercado USD 957 M

Oric Pharmaceuticals

ORIC

Capitalización de mercado USD 957 M